Safety and efficacy of pembrolizumab, radiation therapy, and surgery versus radiation therapy and surgery for stage III soft tissue sarcoma of the extremity (SU2C-SARC032): an open-label, randomised…

Overview of attention for article published in The Lancet, November 2024

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

news: 18 news outlets
blogs: 5 blogs
twitter: 88 X users

reddit: 1 Redditor
guideline: 2 clinical guideline sources
podcasts: 1 podcast

Readers on

mendeley: 61 Mendeley

So far, Altmetric has seen 19 news stories from 18 outlets.

ペムブロリズマブ/放射線/手術はステージ III 軟部肉腫の DFS を改善します

Nipponese.news, 18 Jan 2025

ペンブロリズマブ/放射線/手術ステージIIIの軟部組織のDFSを改善しますストック.adobe.com 第フェーズの所見によると、グレード3、ステージIIIの四肢軟部肉腫患者において、術前放射線療法にペムブロリズマブ（キイトルーダ）を追加し、その後手…

Pembrolizumab/Radiation/Surgery Improves DFS in Stage III Soft Tissue Sarcoma

OncLive, 18 Jan 2025

Improves DFS in Stage III Soft Tissue Sarcoma | Image Credit: © MdBabul - stock.adobe.com The addition of pembrolizumab (Keytruda…

Adding Pembrolizumab to Preoperative Radiotherapy and Surgery Improves DFS in Sarcoma

Oncology Nursing News, 06 Jan 2025

Study shows pembrolizumab (Keytruda) plus radiation and surgery improves disease-free survival in patients with specific types…

Pembrolizumab Added to Preoperative Radiotherapy and Surgery Enhances DFS in Sarcoma

Cancer Network, 02 Jan 2025

The SU2C-SARC032 study evaluating pembrolizumab plus radiotherapy and surgery found the regimen was well tolerated with…

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity, including 15 additional news stories.